Literature DB >> 2662193

Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization.

S Beissert1, M Bergholz, I Waase, G Lepsien, A Schauer, K Pfizenmaier, M Krönke.   

Abstract

Tumor necrosis factor (TNF) produced by macrophages is thought to contribute to the host defense against development of cancer. However, since tumor cells themselves are able to produce TNF, it is conceivable that TNF may also play an adverse pathological role in carcinogenesis. To better understand the functional significance of TNF in neoplastic disease, we have determined the cellular source of TNF activity produced in 10 patients with colorectal cancer. Northern blot analysis of RNAs extracted from fresh biopsy specimens revealed detectable TNF mRNA levels in all instances. By using in situ hybridization of frozen sections, scattered cells expressing TNF mRNA could be discerned. Based on morphological criteria, these TNF-positive cells most likely belong to the macrophage lineage. Macrophages in normal tissue surrounding the tumor did not express TNF mRNA, suggesting that macrophage activation occurs locally at the site of neoplastic transformation. Immunohistochemistry using anti-TNF monoclonal antibodies revealed that less than 1% of tumor-infiltrating macrophages synthesize TNF protein. Thus we present evidence that in colorectal cancer only a small proportion of tumor-infiltrating macrophages produces TNF, indicating that the microenvironment of the tumor provides adequate, yet suboptimal, conditions for macrophage activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2662193      PMCID: PMC297557          DOI: 10.1073/pnas.86.13.5064

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligodeoxynucleotide primer.

Authors:  A K Sood; D Pereira; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

2.  Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.

Authors:  R S Kornbluth; S A Gregory; T S Edgington
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

3.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

5.  Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

6.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  Initial characterization of monoclonal antibodies against human monocytes.

Authors:  V Ugolini; G Nunez; R G Smith; P Stastny; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  Tumor necrosis factor (TNF).

Authors:  L J Old
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

9.  Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor.

Authors:  C M Zacharchuk; B E Drysdale; M M Mayer; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  28 in total

1.  Aloe vera non-decolorized whole leaf extract-induced large intestinal tumors in F344 rats share similar molecular pathways with human sporadic colorectal tumors.

Authors:  Arun R Pandiri; Robert C Sills; Mark J Hoenerhoff; Shyamal D Peddada; Thai-Vu T Ton; Hue-Hua L Hong; Gordon P Flake; David E Malarkey; Greg R Olson; Igor P Pogribny; Nigel J Walker; Mary D Boudreau
Journal:  Toxicol Pathol       Date:  2011-09-21       Impact factor: 1.902

2.  Cross-talk between receptor tyrosine kinase and tumor necrosis factor-α signaling networks regulates apoptosis but not proliferation.

Authors:  Elsa M Beyer; Gavin MacBeath
Journal:  Mol Cell Proteomics       Date:  2012-02-08       Impact factor: 5.911

3.  Differential effects of human blood monocytes on the growth of human tumour cell lines in vitro.

Authors:  H J Parry; R C Rees
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NFkappaB activation.

Authors:  K Harimaya; K Tanaka; Y Matsumoto; H Sato; S Matsuda; Y Iwamoto
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 5.  Gut Microbiota, Inflammation, and Colorectal Cancer.

Authors:  Caitlin A Brennan; Wendy S Garrett
Journal:  Annu Rev Microbiol       Date:  2016-09-08       Impact factor: 15.500

Review 6.  Tumor necrosis factor: an update on basic research and clinical applications.

Authors:  M Schleuning; R Munker
Journal:  Klin Wochenschr       Date:  1990-09-03

7.  Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.

Authors:  K Sonouchi; T A Hamilton; C S Tannenbaum; R R Tubbs; R Bukowski; J H Finke
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  A phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer.

Authors:  W Fiedler; W Zeller; C J Peimann; H J Weh; D K Hossfeld
Journal:  Klin Wochenschr       Date:  1991-04-04

9.  Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions.

Authors:  S Khanolkar-Young; N Rayment; P M Brickell; D R Katz; S Vinayakumar; M J Colston; D N Lockwood
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

10.  Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

Authors:  M S Naylor; G W Stamp; W D Foulkes; D Eccles; F R Balkwill
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.